Entity
Immunic Therapeutics
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
595 6,495Activities
Technologies
Entity types
Location
New York, NY, USA
New York
United States of America
Employees
Scale: 51-200
Estimated: 82
Engaged corporates
3
0 3Added in Motherbase
1 year, 6 months ago
biotech Description
Value proposition
Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases
Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
Privacy Policy: https://imux.com/privacy-policy/
Home - Immunic Therapeutics
Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases.
https://imux.com/
Corporate interactions BETA
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Biotechnology Innovation Organization | Other 12 Jun 2024 | | |
 Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 25 Jul 2024 | | |
 HTGF | High-Tech Gründerfonds Venture Capital and Private Equity Principals | HTGF | High-Tech Gründerfonds Venture Capital and Private Equity Principals | Other 23 Jul 2024 | | |
Similar entities
Loading...
Last news Show all articles
Loading...
Social network dynamics